A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis

Clinical Trial ID: NCT03809663


Learn about this trial.

Check the eligibility requirements, study details, and more.